Works matching IS 13479032 AND DT 2020 AND VI 111 AND IP 10

Results: 52
    1
    2
    3
    4
    5

    Neuroblastoma patient‐derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3780, doi. 10.1111/cas.14610
    By:
    • Hee, Esther;
    • Wong, Meng Kang;
    • Tan, Sheng Hui;
    • Choo, Zhang'E;
    • Kuick, Chik Hong;
    • Ling, Sharon;
    • Yong, Min Hwee;
    • Jain, Sudhanshi;
    • Lian, Derrick W. Q.;
    • Ng, Eileen H. Q.;
    • Yong, Yvonne F. L.;
    • Ren, Mee Hiong;
    • Syed Sulaiman, Nurfarhanah;
    • Low, Sharon Y. Y.;
    • Chua, Yong Wei;
    • Syed, Muhammad Fahmy;
    • Lim, Tony K. H.;
    • Soh, Shui Yen;
    • Iyer, Prasad;
    • Seng, Michaela S. F.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3902, doi. 10.1111/cas.14597
    By:
    • Higa, Nayuta;
    • Akahane, Toshiaki;
    • Yokoyama, Seiya;
    • Yonezawa, Hajime;
    • Uchida, Hiroyuki;
    • Takajo, Tomoko;
    • Kirishima, Mari;
    • Hamada, Taiji;
    • Matsuo, Kei;
    • Fujio, Shingo;
    • Hanada, Tomoko;
    • Hosoyama, Hiroshi;
    • Yonenaga, Masanori;
    • Sakamoto, Akihisa;
    • Hiraki, Tsubasa;
    • Tanimoto, Akihide;
    • Yoshimoto, Koji
    Publication type:
    Article
    12
    13
    14

    R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3770, doi. 10.1111/cas.14604
    By:
    • Kagami, Yoshitoyo;
    • Yamamoto, Kazuhito;
    • Shibata, Taro;
    • Tobinai, Kensei;
    • Imaizumi, Yoshitaka;
    • Uchida, Toshiki;
    • Shimada, Kazuyuki;
    • Minauchi, Koichiro;
    • Fukuhara, Noriko;
    • Kobayashi, Hirofumi;
    • Yamauchi, Nobuhiko;
    • Tsujimura, Hideki;
    • Hangaishi, Akira;
    • Tominaga, Ryo;
    • Suehiro, Youko;
    • Yoshida, Shinichiro;
    • Inoue, Yoshiko;
    • Suzuki, Sachiko;
    • Tokuhira, Michihide;
    • Kusumoto, Shigeru
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3824, doi. 10.1111/cas.14583
    By:
    • Kawata, Yoshiko;
    • Nagasaka, Kazunori;
    • Oda, Katsutoshi;
    • Makii, Chinami;
    • Takeuchi, Makoto;
    • Oki, Shinya;
    • Honjo, Harunori;
    • Kojima, Machiko;
    • Miyagawa, Yuko;
    • Taguchi, Ayumi;
    • Tanikawa, Michihiro;
    • Sone, Kenbun;
    • Hiraike, Haruko;
    • Matsumoto, Yoko;
    • Wada‐Hiraike, Osamu;
    • Ayabe, Takuya;
    • Osuga, Yutaka;
    • Fujii, Tomoyuki
    Publication type:
    Article
    32

    A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3759, doi. 10.1111/cas.14582
    By:
    • Kudo, Masatoshi;
    • Morimoto, Manabu;
    • Moriguchi, Michihisa;
    • Izumi, Namiki;
    • Takayama, Tetsuji;
    • Yoshiji, Hitoshi;
    • Hino, Keisuke;
    • Oikawa, Takayoshi;
    • Chiba, Tetsuhiro;
    • Motomura, Kenta;
    • Kato, Junko;
    • Yasuchika, Kentaro;
    • Ido, Akio;
    • Sato, Takashi;
    • Nakashima, Daisuke;
    • Ueshima, Kazuomi;
    • Ikeda, Masafumi;
    • Okusaka, Takuji;
    • Tamura, Kazuo;
    • Furuse, Junji
    Publication type:
    Article
    33

    Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3576, doi. 10.1111/cas.14581
    By:
    • Nishio, Miki;
    • To, Yoko;
    • Maehama, Tomohiko;
    • Aono, Yukari;
    • Otani, Junji;
    • Hikasa, Hiroki;
    • Kitagawa, Akihiro;
    • Mimori, Koshi;
    • Sasaki, Takehiko;
    • Nishina, Hiroshi;
    • Toyokuni, Shinya;
    • Lydon, John P.;
    • Nakao, Kazuwa;
    • Wah Mak, Tak;
    • Kiyono, Tohru;
    • Katabuchi, Hidetaka;
    • Tashiro, Hironori;
    • Suzuki, Akira
    Publication type:
    Article
    34
    35
    36
    37
    38

    Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576
    By:
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Satouchi, Miyako;
    • Goto, Yasushi;
    • Niho, Seiji;
    • Nogami, Naoyuki;
    • Hida, Toyoaki;
    • Takahashi, Toshiaki;
    • Sakakibara‐Konishi, Jun;
    • Morise, Masahiro;
    • Nagasawa, Takashi;
    • Suzuki, Mie;
    • Ohkura, Masayuki;
    • Fukuhara, Kei;
    • Thurm, Holger;
    • Peltz, Gerson;
    • Nishio, Makoto
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Propensity score analysis of overall survival between first‐ and second‐generation EGFR‐TKIs using real‐world data.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3705, doi. 10.1111/cas.14560
    By:
    • Ito, Kentaro;
    • Murotani, Kenta;
    • Kubo, Akihito;
    • Kunii, Eiji;
    • Taniguchi, Hirokazu;
    • Shindoh, Joe;
    • Asada, Kazuhiro;
    • Imaizumi, Kazuyoshi;
    • Takahashi, Kosuke;
    • Karayama, Masato;
    • Okuno, Motoyasu;
    • Inui, Naoki;
    • Hataji, Osamu;
    • Morikawa, Sayako;
    • Hayai, Shunsaku;
    • Suda, Takafumi;
    • Abe, Takashi;
    • Tsuda, Takeshi;
    • Yamagichi, Teppei;
    • Kimura, Tomoki
    Publication type:
    Article
    48
    49
    50